Abstract
It is well known that loss of tumor suppressor genes and more generally of antiproliferative genes plays a key role in the development of most tumors. We report here the cloning of the mouse BTG3 gene and show that its human counterpart maps on chromosome 21. This evolutionarily conserved gene codes for a 30 kDa protein and is expressed in most adult murine and human tissues analyzed. However, we demonstrate that its expression is cell cycle dependent and peaks at the end of the G1 phase. This gene is homologous to the human BTG1, BTG2 and TOB genes which were demonstrated to act as inhibitors of cell proliferation. Its description allowed us to define better this seven gene family (the BTG gene family) at the structural level and to speculate about its physiological role in normal and tumoral cells. This family is mainly characterized by the presence of two conserved domains (BTG boxes A and B) of as yet undetermined function which are separated by a non-conserved 20–25 amino acid sequence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guéhenneux, F., Duret, L., Callanan, M. et al. Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia 11, 370–375 (1997). https://doi.org/10.1038/sj.leu.2400599
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400599
Keywords
This article is cited by
-
Hypothesis-driven genome-wide association studies provide novel insights into genetics of reading disabilities
Translational Psychiatry (2022)
-
TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2
BMC Cancer (2021)
-
Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancer
Journal of Cancer Research and Clinical Oncology (2015)
-
C. elegans FOG-3/Tob can either promote or inhibit germline proliferation, depending on gene dosage and genetic context
Oncogene (2013)
-
Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma
Tumor Biology (2013)